Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Grant Funding Automated Genome Editing System

A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique. . . . → Read More: Grant Funding Automated Genome Editing System

America’s Overdose Epidemic In Perspective

This chart, from Statista, compares the rate of drug-induced deaths in the U.S. with other countries. . . . → Read More: America’s Overdose Epidemic In Perspective

Students Design Prototype Soft Artificial Heart

Two graduate students in materials science and engineering designed and tested an artificial heart made with soft plastics for eventual use as an implanted device. . . . → Read More: Students Design Prototype Soft Artificial Heart

Broad Institute in Crispr Licensing Program

One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology. . . . → Read More: Broad Institute in Crispr Licensing Program

Device Shown to Reduce Migraine Occurrence

A clinical trial shows an electronic device worn with headphones reduces the number of days with migraines among people with a history of their occurrence. . . . → Read More: Device Shown to Reduce Migraine Occurrence

Little Health Impact Found from Engineered Mosquitoes

An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans. . . . → Read More: Little Health Impact Found from Engineered Mosquitoes

Game App Improves Memory Among Cognitive Impaired

A brain training game for an iPad was shown in a clinical study to improve the memory of people with mild cognitive impairment, a precursor stage to dementia. . . . → Read More: Game App Improves Memory Among Cognitive Impaired

Glaxo Using Artificial Intelligence for Drug Discovery

Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets. . . . → Read More: Glaxo Using Artificial Intelligence for Drug Discovery

Nerve Stimulation Approved for Children’s Epilepsy

The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old. . . . → Read More: Nerve Stimulation Approved for Children’s Epilepsy

Start-Up to Offer Neuro Disorder Speech Analytics App

A start-up enterprise in Germany is commercializing a software app to detect early signs of cognitive decline, found in dementia and other neurodegenerative disorders. . . . → Read More: Start-Up to Offer Neuro Disorder Speech Analytics App